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Venous anomalies discovered on cardiac implantable electronic device (CIED) 
implantation may hinder both the insertion of cardiac leads and the selection of 
their optimal intraventricular placement. Such venous anomalies may be a result 
of congenital vascular defects, e.g. anomalies of the foetal venous system, or be 
a consequence of earlier cardio- or thoracosurgical procedures. In the case of the 
latter, the extent of morphometric changes to mediastinal structures may depend 
on the extent of prior lung tissue resection. This paper presents 3 cases of CIED im-
plantation procedures performed in patients with systemic veins topographically and 
morphometrically altered post lung surgery. (Folia Morphol 2017; 76, 2: 322–325)
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INTRODUCTION
The indications for cardiac implantable electronic 
devices (CIED) have expanded considerably over the 
years: from pacemakers (PMs) used solely for brady-
arrhythmia treatment, through implantable cardio-
verter defibrillators (ICDs) to control life-threatening 
arrhythmias, to cardiac resynchronisation therapy 
(CRT) devices [3, 8].
The venous system is used in most of the current 
CIED implantation procedures for cardiac lead inser-
tion. The conventional techniques of cardiac lead 
insertion by cephalic vein (CV) or jugular vein (JV) 
cut-down have been expanded by adding axillary vein 
(AV) or subclavian vein (SV) puncture with the use of 
special kits [2, 9].
The use of the CV cut-down technique may be 
limited by congenitally unfavourable venous morpho-
metric parameters or the course of veins altered as 
a result of surgery. On the other hand, with the 
AV/SV puncture technique there is a higher risk of 
accidental damage to nearby anatomical structures 
resulting in significant complications including 
pneumothorax, venous or arterial haemorrhaging 
into the pleural cavity. The risk of these complications 
increases with atypical spatial topography of the veins 
used at that stage of a CIED implantation procedure [7].
The effectiveness of subsequent stages of cardiac 
lead advancement through the venous system is de-
termined by favourable morphometric parameters of 
further vessels: the brachiocephalic vein (BCV) and 
the superior vena cava (SVC) as far as the selected 
lead placement site. Problems at this stage may be 
due to embryonic systemic venous abnormalities or, 
alternatively, to past cardio or cardiothoracic surgery 
[1, 4, 6].
Due to the fact that such co-occurrence of clinical 
conditions is very rare, we presented specific altera-
tions of morphometric and topographic parameters 
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of venous vessels observed during de-novo CIED im-
plantation procedures in three patients post lung 
tissue resection.
CASE REPORTS
In the period between January 2012 and Septem-
ber 2016, out of 1,901 de-novo CIED implantation 
procedures performed at our centre, there were three 
where patients were post thoracic surgery due to 
malignant neoplasm.
The CIED implantation procedures were conduct-
ed according to a standard protocol, with local ligno-
caine anaesthesia in the infraclavicular region. Device 
pockets were formed subcutaneously anterior to the 
pectoral muscle, while cardiac leads were introduced 
into heart chambers via a transvenous route. Two of 
these patients received ventricular pacing devices 
(VVIR mode) and one received an atrioventricular pac-
ing device (DDDR mode). Before their CIED implanta-
tion procedures, the patients stayed in an Intensive 
Care Unit, where their heart rates were effectively 
controlled with medication, precluding any need for 
temporary cardiac pacing.
CIED ImPlANTATION POST RIghT  
TOTAl PNEUmONECTOmy
Case 1. A 72-year-old male, qualified for a PM 
implantation due to Adams-Stokes episodes result-
ing from atrioventricular conduction disorder with 
bradyarrhythmias and persistent atrial fibrillation. The 
patient had a history of right total pneumonectomy 
(in 1991) due to lung cancer. On April 6, 2012, there 
was an unsuccessful attempt at PM implantation on 
the right side. Four days later, a device with VVI pacing 
mode (a Talos SR pacemaker [Biotronik] with a 5076-
58 cardiac lead [Medtronic]) was implanted on the 
left side. Unfavourable CV morphometry prompted 
cardiac lead insertion via SV puncture (Fig. 1A).
Case 2. An 80-year-old male, qualified to receive 
a PM due to Adams-Stokes episodes caused by episodes 
of bradyarrhythmia resulting from sinus node dysfunc-
tion. The patient had had a pneumonectomy many 
years earlier due to squamous cell carcinoma of the 
right lung. On July 27, 2012, the patient received a Talos 
SR pacemaker (VVI mode) (Biotronik) with a Setrox S60 
cardiac lead introduced via left SV puncture (Fig. 2B).
The course of the CV prevented lead advancement 
via a cut-down technique. Despite contrast-enhanced 
vessel imaging, attempts at SV puncture resulted in sev-
eral instances of SV puncture, with no clinical sequelae.
CIED ImPlANTATION POST lEfT  
INfERIOR lObECTOmy
Case 3. A 69-year-old male, qualified to undergo 
PM implantation due to an abortive form of Adams-
Stokes attacks during recorded electrocardiographic 
episodes of sinus bradycardia with trifascicular block: 
prolonged PQ (0.22 s), left anterior hemiblock, and 
right bundle branch block. The patient reported a pre-
vious surgical treatment of thymoma with unilateral, 
lower left lobectomy in 1995. On September 5, 2016, 
there was a failed attempt to implant a CIED on the 
left side (Fig. 2A, B). A computed tomography (CT) 
examination conducted on the next day revealed the 
cause of the failure: the lumen of the left BCV mis-
shaped by the aortic arch, in the form of segmental 
compression of the vein with local lumen reduction 
to 4.0 mm; at the same time, the images confirmed 
favourable lead insertion conditions on the right side 
(Fig. 3A, B). On September 7, 2016, an Etrinsa 6 DR-T 
pacemaker (Biotronik) was implanted with a Solia S 
60 ventricular lead inserted via CV cut-down and 
a Solia S 53 atrial lead inserted via SV puncture.
CONClUSIONS
The cases presented here are characterised by 
a combination of medical, pulmonological, and cardio- 
logical procedures that had occurred in a random or-
der. The diagnosed neoplastic conditions required vari-
ous amounts of lung tissue to be resected. The degree 
of topographic alterations of mediastinal structures 
and veins, observed also during CIED implantation 
procedures, correlates with the volume of resected 
lung tissue: pneumonectomy vs. lobectomy [1].
Venography with the use of contrast to visualise 
CV, AV, and SV lumina can only to some extent help 
with the initial decision on the side of CIED implan-
tation and the technique of venous access. In the 
cases presented here it is difficult to unequivocally 
demonstrate a correlation between the effect of past 
thoracic surgery procedures on anatomical features 
of the CV that proved unfavourable for cardiac lead 
insertion. The extent of data on mediastinal vessels 
obtained via venography proved to be insufficient. 
In the case of congenital defects and post-thoracic-
surgery patients who require catheter and/or cardiac 
lead insertion into the venous system, venography 
can be supplemented with a diagnostically valid CT 
examination [11].
In the cases presented here, after total pneumo-
nectomy the course of cardiac leads on fluoroscopy, 
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Figure 1. A, B. Postero-arterial view chest X-ray images of both patients: the heart and the mediastinum with the right superior vena cava 
are shifted to the right. In both cases, the cardiac lead is moulded by the veins used for its insertion, which shows a significantly altered 
topography of those vessels. The lead tip placement in the right ventricle also clearly differs from its conventional location (single black 
arrow); VCS — vena cava superior; BCV — brachiocephalic vein.
Figure 2. A. A fluoroscopic image of the cardiac lead blocked during its advancement along the brachiocephalic vein (BCV); 
B. Contrast administration helped visualise contrast flow impairment in the medial segment of the BCV with contrast-enhanced 
compensatory collateral circulation; C, D. The visualised course of cardiac leads of a DDD device implanted on September 7, 2016.
Figure 3. Computed tomography (CT): topographies of the brachiocephalic vein (BCV) and superior vena cava (SVC) in relation to the adjacent 
anatomical structures of the chest. A. The left BCV (LBCV) segmentally compressed by the aortic arch; B. A frontal reconstruction adjusted to 
visualise the BCV-right superior vena cava confluence; C. The relation of the evaluated structures in an axial CT plane.
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significantly documents a clear “shift” of the left BCV 
and its drainage point into the SVC to the right with 
respect to the typical topography of those vessels in the 
mediastinum. Nonetheless, cardiac leads were success-
fully advanced through this venous segment. Despite 
a much lesser extent of tissue destruction, the resection 
of a single lobe of the left lung still made it impossible 
to advance a cardiac lead through the left BCV.
In the first two of the three cases presented here 
fluoroscopy provided only a limited amount of data 
as to the precise location of leads in heart chambers. 
Therefore, the operators generally relied on electro-
physiological parameters: the endocardial cardiac 
stimulation threshold and the recorded intracardiac 
signal magnitude.
The sporadic co-occurrence of events from past 
medical history and the course of CIED implantation 
procedures did not allow the authors to draw far-
reaching conclusions; however, some of the com-
ments regarding the performed procedures may be 
useful in similar cases.
Expanded indications for CIED implantation in 
combination with the observed increased incidence 
of neoplastic diseases that require surgical treatment 
involving lung tissue resection, are sure to increase 
co-occurrence of similar cases [5, 10].
In the case of procedures performed in post-tho-
racic-surgery patients and requiring catheter and/or 
lead insertion into the venous system, irrespective of 
the standard venography, there seems to be an indica-
tion for a prior CT vessel reconstruction adjusted to 
the type of the planned invasive procedure.
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